VeonGen Therapeutics | Finanzwire

Basculer en Français

9529	Companies
187479	Keywords
119514	Articles
100217	Press releases

Home
Companies
VeonGen Therapeutics

BRIEF

published on 08/21/2025 at 14:05, 3 months 25 days ago

VeonGen Therapeutics Secures FDA RMAT Designation for VG801 in Stargardt Disease

VeonGen Therapeutics Stargardt Disease VG801 Gene Therapy FDA RMAT Designation ABCA4 Gene
PRESS RELEASE

published on 08/21/2025 at 14:00, 3 months 25 days ago

VeonGen Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for VG801 Gene Therapy for Stargardt Disease
VeonGen Therapeutics receives FDA RMAT designation for VG801 gene therapy targeting Stargardt Disease, a milestone in genetic medicine development

Genetic Medicine VeonGen Therapeutics Stargardt Disease VG801 Gene Therapy FDA RMAT Designation
BRIEF

published on 06/05/2025 at 14:05, 6 months 10 days ago

VeonGen Therapeutics Rebrands and Advances Gene Therapy for Stargardt Disease

Clinical Trials Gene Therapy FDA Designation VeonGen Therapeutics Stargardt Disease
PRESS RELEASE

published on 06/05/2025 at 14:00, 6 months 10 days ago

ViGeneron Rebrands as VeonGen Therapeutics and Announces FDA Rare Pediatric Disease Designation and Clinical Progress for Lead Gene Therapy VG801 in Stargardt Disease
VeonGen Therapeutics (formerly ViGeneron) announces FDA Rare Pediatric Disease Designation and clinical progress for lead gene therapy VG801 in Stargardt Disease, advancing genetic medicine in ophthalmology and beyond

Gene Therapy Clinical Progress VeonGen Therapeutics Stargardt Disease FDA Rare Pediatric Disease Designation

Accesswire

Published on 12/15/2025 at 18:15, 56 minutes ago

Athena Gold Closes Second Tranche of Non-brokered Private Placement and Increases Offering Due to Strong Demand
Published on 12/15/2025 at 16:35, 2 hours 36 minutes ago

Stillwater Critical Minerals Announces Upsize of Bought Deal LIFE Private Placement for Gross Proceeds of C$15 Million
Published on 12/15/2025 at 15:00, 4 hours 11 minutes ago

Kingfisher Reports Annual General Meeting Voting Results
Published on 12/15/2025 at 15:00, 4 hours 11 minutes ago

Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Published on 12/15/2025 at 14:30, 4 hours 41 minutes ago

Unusual Machines Congratulates Customers Selected for the Army's PBAS Tranche 1.1, Including Envision Technology and Strategic Logix

View all ACCESSWIRE

EQS Group

Published on 12/15/2025 at 18:15, 56 minutes ago

Results of EQT’s mandatory simplified cash tender offer for Waga Energy’s remaining shares
Published on 12/15/2025 at 18:07, 1 hour 3 minutes ago

POS-Transaction in Own Shares
Published on 12/15/2025 at 18:00, 1 hour 11 minutes ago

LIGHTON: Adjustment of ARR target for FY 2025
Published on 12/15/2025 at 17:45, 1 hour 26 minutes ago

EQS-Adhoc: Airbus SE: Airbus reports share buybacks for week starting 8 December 2025
Published on 12/15/2025 at 17:38, 1 hour 32 minutes ago

Stabilus SE approves share buyback program with a volume of up to €20 million

Les Echos

Published on 12/15/2025 at 18:30, 41 minutes ago

MCH PRIVATE EQUITY AND EURAZEO ENTER INTO AN EXCLUSIVE AGREEMENT WITH ARDIAN FOR THE SALE OF THEIR MAJORITY STAKE IN FERMAX
Published on 12/15/2025 at 18:05, 1 hour 6 minutes ago

Covivio - Treasury shares transactions between December 8th , 2025 and December 12th, 2025
Published on 12/15/2025 at 17:45, 1 hour 25 minutes ago

ENGIE strengthens the resilience of the Belgian electricity system with new flexible capacities
Published on 12/15/2025 at 17:40, 1 hour 31 minutes ago

LISI joins the SBF 120 and CAC Mid 60 indices
Published on 12/15/2025 at 17:35, 1 hour 36 minutes ago

DISCLOSURE OF TRANSACTIONS IN OWN SHARES FROM DECEMBER 8 TO DECEMBER 12, 2025

View all LES ECHOS COMFI WIRE